XTX Topco’s Unity Biotechnology UBX Stock Holding History

XTX Topco’s Portfolio UBX Stock Details UBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13,985	Closed	-$782	–	3822
2025 Q3	$782	Buy	+13,985	New	+$4.01K	﹤0.01%	2474
2024 Q1	–	Sell	-20,971	Closed	-$40.5K	–	2337
2023 Q4	$40.5K	Buy	+20,971	New	+$39K	0.01%	1268
2022 Q2	–	Sell	-4,062	Closed	-$45K	–	1116
2022 Q1	$45K	Buy	4,062 +359	+10%	+$4.03K	0.02%	600
2021 Q4	$54K	Buy	+3,703	New	+$80.9K	0.03%	554

XTX Topco's UBX Position: Q4 2025 in Review

XTX Topco sold out of Unity Biotechnology (UBX) in Q4 2025, closing a stake of 13,985 shares — an estimated $782 sold.

XTX Topco first reported a position in UBX in Q4 2021 and held it in 4 quarters. The position peaked at $54K in Q4 2021. 0 funds tracked by Wall St. Rank hold UBX as of Q4 2025.

XTX Topco reported no remaining Unity Biotechnology position as of Q4 2025 after selling out during the quarter.
XTX Topco sold 13,985 Unity Biotechnology shares in Q4 2025, an estimated $782.
XTX Topco first reported a position in Unity Biotechnology in Q4 2021 and held it in 4 quarters.
XTX Topco's Unity Biotechnology position peaked at $54K in Q4 2021.
0 funds tracked by Wall St. Rank held Unity Biotechnology as of Q4 2025.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.